Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TECH - US09073M1045 - Common Stock

65.7 USD
+1.12 (+1.73%)
Last: 1/9/2026, 4:30:00 PM
65.19 USD
-0.51 (-0.78%)
After Hours: 1/9/2026, 4:30:00 PM
Fundamental Rating

6

TECH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year TECH was profitable.
TECH had a positive operating cash flow in the past year.
In the past 5 years TECH has always been profitable.
TECH had a positive operating cash flow in each of the past 5 years.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

The Return On Assets of TECH (3.04%) is better than 73.68% of its industry peers.
Looking at the Return On Equity, with a value of 3.91%, TECH is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
TECH has a Return On Invested Capital of 9.33%. This is amongst the best in the industry. TECH outperforms 84.21% of its industry peers.
TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is significantly below the industry average of 14.00%.
The last Return On Invested Capital (9.33%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROIC 9.33%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

TECH's Profit Margin of 6.32% is fine compared to the rest of the industry. TECH outperforms 73.68% of its industry peers.
TECH's Profit Margin has declined in the last couple of years.
The Operating Margin of TECH (22.13%) is better than 91.23% of its industry peers.
In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
TECH has a Gross Margin of 66.83%. This is amongst the best in the industry. TECH outperforms 89.47% of its industry peers.
In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TECH has less shares outstanding
Compared to 5 years ago, TECH has more shares outstanding
TECH has a worse debt/assets ratio than last year.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TECH has an Altman-Z score of 12.43. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
TECH has a better Altman-Z score (12.43) than 96.49% of its industry peers.
The Debt to FCF ratio of TECH is 1.34, which is an excellent value as it means it would take TECH, only 1.34 years of fcf income to pay off all of its debts.
TECH has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. TECH outperforms 89.47% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that TECH is not too dependend on debt financing.
TECH's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. TECH outperforms 59.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Altman-Z 12.43
ROIC/WACC0.85
WACC10.92%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 4.22 indicates that TECH has no problem at all paying its short term obligations.
The Current ratio of TECH (4.22) is better than 66.67% of its industry peers.
TECH has a Quick Ratio of 2.81. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
TECH's Quick ratio of 2.81 is in line compared to the rest of the industry. TECH outperforms 57.89% of its industry peers.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 2.81
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

TECH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
TECH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.00%.
The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%

3.2 Future

Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y4.76%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.04 indicates a quite expensive valuation of TECH.
Compared to the rest of the industry, the Price/Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 68.42% of the companies listed in the same industry.
TECH is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 29.37, the valuation of TECH can be described as expensive.
71.93% of the companies in the same industry are more expensive than TECH, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, TECH is valued a bit more expensive.
Industry RankSector Rank
PE 34.04
Fwd PE 29.37
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

TECH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TECH is cheaper than 61.40% of the companies in the same industry.
63.16% of the companies in the same industry are more expensive than TECH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 45.69
EV/EBITDA 27.22
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)7.15
PEG (5Y)3.03
EPS Next 2Y7.66%
EPS Next 3Y10.98%

4

5. Dividend

5.1 Amount

TECH has a yearly dividend return of 0.54%, which is pretty low.
TECH's Dividend Yield is rather good when compared to the industry average which is at 0.09. TECH pays more dividend than 92.98% of the companies in the same industry.
With a Dividend Yield of 0.54, TECH pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

TECH pays out 65.26% of its income as dividend. This is not a sustainable payout ratio.
The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65.26%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (1/9/2026, 4:30:00 PM)

After market: 65.19 -0.51 (-0.78%)

65.7

+1.12 (+1.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners107.49%
Inst Owner Change0%
Ins Owners0.25%
Ins Owner Change3.89%
Market Cap10.24B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target71.26 (8.46%)
Short Float %6.06%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)0.66%
PT rev (3m)6.39%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-5.8%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE 34.04
Fwd PE 29.37
P/S 8.41
P/FCF 45.69
P/OCF 40.74
P/B 5.21
P/tB 16.08
EV/EBITDA 27.22
EPS(TTM)1.93
EY2.94%
EPS(NY)2.24
Fwd EY3.4%
FCF(TTM)1.44
FCFY2.19%
OCF(TTM)1.61
OCFY2.45%
SpS7.81
BVpS12.62
TBVpS4.09
PEG (NY)7.15
PEG (5Y)3.03
Graham Number23.41
Profitability
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROCE 11.3%
ROIC 9.33%
ROICexc 9.93%
ROICexgc 24.48%
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
FCFM 18.41%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Debt/EBITDA 0.8
Cap/Depr 25.63%
Cap/Sales 2.24%
Interest Coverage 14.5
Cash Conversion 66.94%
Profit Quality 291.58%
Current Ratio 4.22
Quick Ratio 2.81
Altman-Z 12.43
F-Score5
WACC10.92%
ROIC/WACC0.85
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y4.76%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y12.84%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 3 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Overvalued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


What is the financial health of BIO-TECHNE CORP (TECH) stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


Is the dividend of BIO-TECHNE CORP sustainable?

The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 65.26%.